SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-186755
Filing Date
2018-06-07
Accepted
2018-06-07 16:02:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d603897d424b5.htm 424B5 316693
2 GRAPHIC g603897g85f37.jpg GRAPHIC 31347
3 GRAPHIC g603897g85f37_268.jpg GRAPHIC 44219
  Complete submission text file 0001193125-18-186755.txt   422094
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207848 | Film No.: 18886496
SIC: 2834 Pharmaceutical Preparations